To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva
Clinical trial NCT05090891 · RECRUITING
Trial details
- NCT number
- NCT05090891
- Sponsor
- Incyte Corporation
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-05
- Primary completion
- 2027-07-30
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.